Insmed Inc (INSM) Stock: Beyond the Surface of Its Performance?
Truist has recently initiated Insmed Inc (INSM) stock to Buy rating, as announced on April 23, 2024, according to Finviz. Earlier, on February 15, 2024, Wolfe Research had initiated the stock to Outperform, setting a price target of $42. Wells Fargo also initiated Overweight rating with a price target of $55. Additionally, JP Morgan resumed […]
What’s Driving Insmed Inc (INSM) Stock’s -7.96% Plunge Over the Past Month?
Truist has recently initiated Insmed Inc (INSM) stock to Buy rating, as announced on April 23, 2024, according to Finviz. Earlier, on February 15, 2024, Wolfe Research had initiated the stock to Outperform, setting a price target of $42. Wells Fargo also initiated Overweight rating with a price target of $55. Additionally, JP Morgan resumed […]
Analysts Predict a $48 Target for Insmed Inc (INSM) Stock—What Could Drive It There?
Truist has recently initiated Insmed Inc (INSM) stock to Buy rating, as announced on April 23, 2024, according to Finviz. Earlier, on February 15, 2024, Wolfe Research had initiated the stock to Outperform, setting a price target of $42. Wells Fargo also initiated Overweight rating with a price target of $55. Additionally, JP Morgan resumed […]
Insmed Inc (INSM) Stock: More Resilient Than It Appears
Truist has recently initiated Insmed Inc (INSM) stock to Buy rating, as announced on April 23, 2024, according to Finviz. Earlier, on February 15, 2024, Wolfe Research had initiated the stock to Outperform, setting a price target of $42. Wells Fargo also initiated Overweight rating with a price target of $55. Additionally, JP Morgan resumed […]
Insmed Inc (INSM) Stock: More Strategic Than Meets the Eye
Truist has recently initiated Insmed Inc (INSM) stock to Buy rating, as announced on April 23, 2024, according to Finviz. Earlier, on February 15, 2024, Wolfe Research had initiated the stock to Outperform, setting a price target of $42. Wells Fargo also initiated Overweight rating with a price target of $55. Additionally, JP Morgan resumed […]
Truist Issues Buy Rating for Insmed Inc (INSM) Stock
Truist has recently initiated Insmed Inc (INSM) stock to Buy rating, as announced on April 23, 2024, according to Finviz. Earlier, on February 15, 2024, Wolfe Research had initiated the stock to Outperform, setting a price target of $42. Wells Fargo also initiated Overweight rating with a price target of $55. Additionally, JP Morgan resumed […]
Insmed Inc (INSM) Stock Rated Buy by Truist
Truist has recently initiated Insmed Inc (INSM) stock to Buy rating, as announced on April 23, 2024, according to Finviz. Earlier, on February 15, 2024, Wolfe Research had initiated the stock to Outperform, setting a price target of $42. Wells Fargo also initiated Overweight rating with a price target of $55. Additionally, JP Morgan resumed […]
What’s Fueling Insmed Inc (INSM) Stock’s 30.08% Gain Above Its 200-Day SMA?
Truist has recently initiated Insmed Inc (INSM) stock to Buy rating, as announced on April 23, 2024, according to Finviz. Earlier, on February 15, 2024, Wolfe Research had initiated the stock to Outperform, setting a price target of $42. Wells Fargo also initiated Overweight rating with a price target of $55. Additionally, JP Morgan resumed […]
Insmed Inc (INSM) Stock Posted a Gross Margin of 75.77% Over the Past Year: Is This Justifiable?
Truist has recently initiated Insmed Inc (INSM) stock to Buy rating, as announced on April 23, 2024, according to Finviz. Earlier, on February 15, 2024, Wolfe Research had initiated the stock to Outperform, setting a price target of $42. Wells Fargo also initiated Overweight rating with a price target of $55. Additionally, JP Morgan resumed […]
Insmed Inc (INSM) Stock Sees Market Value Hit $13.00 billion: What Are the Implications?
Truist has recently initiated Insmed Inc (INSM) stock to Buy rating, as announced on April 23, 2024, according to Finviz. Earlier, on February 15, 2024, Wolfe Research had initiated the stock to Outperform, setting a price target of $42. Wells Fargo also initiated Overweight rating with a price target of $55. Additionally, JP Morgan resumed […]
